Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Patent
1994-12-01
1998-05-19
Budens, Robert D.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
4241421, 4241481, 435 7021, 4351722, 53038815, 53038835, 5303911, 5303917, C12N 524, C07K 1610, A61K 3942
Patent
active
057535035
ABSTRACT:
The invention is directed to human monoclonal antibodies specific for the gp41 envelope protein of human immunodeficiency virus type 1 (HIV-1). Specifically disclosed are the human monoclonal antibodies produced by the cell lines 3D6 having ECACC Accession No. 87110301, 24G3 having ECACC Accession No. 90091702 and 25C2 having ECACC Accession No. 80120601.
REFERENCES:
patent: 5087557 (1992-02-01), McClure
Fahey et al., "Status of Immune-based Therapies in HIV Infection and AIDS," Clin. Exp. Immunol. 88:1-5, 1992.
Fox, J.L., "No Winners Against AIDS," Bio/Technology 12:128, Feb. 1994.
Grunow Roland
Jungbauer Alois A.
Katinger Hermann W. D.
Porstmann Tomas
Steindl Franz J.
Budens Robert D.
Katinger Hermann W. D.
LandOfFree
Human monoclonal anti-HIV-I-antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monoclonal anti-HIV-I-antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal anti-HIV-I-antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1852253